Sadaf Haiyat | Cancer Diagnosis | Best Researcher Award

Posted on by Best Paper Award

Assist Prof Dr. Sadaf Haiyat , Cancer Diagnosis, Best Researcher Award

Assistant Professor at Mahamana Pandit Madan Mohan Malviya Cancer Centre /Tata Memorial Hospital Varanasi, India

Summary:

Dr. Sadaf Haiyat is a distinguished pathologist with extensive expertise in hematology, clinical pathology, and molecular pathology. With an MD in Pathology from Aligarh Muslim University, Dr. Haiyat has over seven years of experience in various pathology disciplines, including significant post-MD roles. Notably, Dr. Haiyat has contributed to the field through independent research on Syndecan-1 as a diagnostic biomarker, which has been published as a book. Currently serving as a Consultant Pathologist and Assistant Professor at Tata Memorial Cancer Centre/MPMMCC in Varanasi, Dr. Haiyat is recognized for excellence in pathology practice, quality control, and medical education. Dr. Haiyat has received multiple awards, including the “Young Clinician in Pathology Award” and accolades for research presentations and diagnostic challenges.

Professional Profile:

👩‍🎓Education:

  • MD (Pathology): 2016, Aligarh Muslim University (AMU), Aggregate – 66%
  • MBBS: 2011, Aligarh Muslim University (AMU), Aggregate – 60%

Professional Experience:

Dr. Sadaf Haiyat has a total of 7 years of professional experience in pathology, including 4.5 years post-MD. During her tenure as a Junior Resident at J.N.M.C.H, A.M.U, Aligarh from June 2013 to June 2016, she gained extensive experience teaching undergraduate MBBS and BDS students, conducting practical classes, and participating actively in postgraduate seminars and journal clubs. Her work encompassed a broad range of pathology disciplines, including hematology, leukemia and cytochemistry reporting, peripheral smears, bone marrow aspiration and biopsy reporting, coagulation studies, anemia profile, clinical pathology, chemical pathology, immunology, serology, blood bank, and histopathology.

From April 2017 to April 2020, Dr. Haiyat served as a Senior Resident / Demonstrator at the same institution, where she further honed her skills in hematology, hemato-oncopathology, chemical pathology, clinical pathology, blood bank/transfusion medicine, histopathology, and cytopathology, with additional expertise in frozen sections and immunofluorescence.

As a Laboratory Head and Consultant Pathologist at Popular Multispeciality Hospital, Varanasi, U.P. from August 2020 to May 2021, Dr. Haiyat supervised and approved reports in hematology, biochemistry, clinical pathology, body fluids, and immunology, ensuring strict adherence to quality control measures and ISO 150189:2012 guidelines. She also participated in the administration and management of the laboratory, including the training of technicians and staff.

In her subsequent role as a Consultant Pathologist at Dr. Lal Path NRL, Reference Lab, New Delhi from August 2021 to February 2021, Dr. Haiyat independently reported on various pathology disciplines including hematology, peripheral smears, bone marrow aspiration, biopsies, clinical pathology, cytopathology, histopathology, and oncopathology.

Currently, Dr. Haiyat serves as a Consultant Pathologist and Assistant Professor at Tata Memorial Cancer Centre/MPMMCC, Varanasi, Uttar Pradesh, where she has started a Molecular Pathology Lab. Her responsibilities include independently reporting on histopathology, oncopathology, hematology, hemato-oncology, peripheral smears, cytochemistry, bone marrow aspiration, biopsies, immunophenotyping interpretation, and coagulation testing. Additionally, she supervises audits for NABL Pathology, participates in EQAS of CAP and NABL, and is involved in multidisciplinary meetings, training of residents and technical staff, teaching, research, and administrative work.

Research Interest:

  • Hematology and Hemato-Oncopathology
  • Diagnostic Biomarkers
  • Clinical and Chemical Pathology
  • Cytopathology and Histopathology
  • Molecular Pathology
  • Blood Bank and Transfusion Medicine
  • Quality Control in Pathology Laboratories

Awards:

“Young Clinician in Pathology Award” at the 2nd Annual Medical Summit and Venus International Medical Awards, Park Hyatt, Chennai, 6th April 2019.

World Championship 2018 in Hematology for the research article titled “A challenging case of Hemophilia A with first presentation at the age of 16 as monoarticular hemophiliac arthropathy: A diagnostic enigma” by the Journal for Hematology.

1st Prize in Oral Paper Presentation on “A Cytological and Histomorphological Case Study Of an Unusual Occurrence of Gonadoblastoma with Seminoma and Yolk Sac Tumor In An Anatomically Normal Male Child” at UP CYTOCON 2015, 3rd Annual Conference Of Indian Academy Of Cytopathologists, 13th September 2015.

Best Poster Award entitled “Cryptococcal Meningitis Presenting As Multiple Fractures in an Immunocompetent Individual-An Unusual Presentation” at NEUROCON 2015, XXI Annual Conference of Neuroscience Society (UP & UK), J.N.M.C, A.M.U., Aligarh, 14th February 2015.

3rd Prize in Poster Presentation on “Primary Lymphoma of Bone: An Oncological Paradox” at the International Symposium on Oncologic Pathology, Department of Pathology, J.N.M.C, A.M.U., Aligarh, 25th January 2018.

Carlos Prudencio | Serology | Research Advancement Paper Award

Posted on by Best Paper Award

Dr. Carlos Prudencio, Serology, Research Advancement Paper Award

Doctorate at Instituto Adolfo Lutz, Brazil

Summary:

Dr. Carlos Prudencio is a leading researcher in the field of molecular biology and immunology, currently serving at the Immunology Center of the Adolfo Lutz Institute in São Paulo. With a robust academic background, including a PhD in Genetics from the Federal University of Uberlândia and postdoctoral research in Biotechnology and Preventive Veterinary Medicine, Dr. Prudencio has made significant contributions to the scientific community. His expertise in phage display and the development of diagnostic tools and vaccines has been instrumental in advancing public health initiatives. Dr. Prudencio continues to drive innovative research, particularly in understanding and combating viral pathogens, with numerous projects funded by top research agencies.

Professional Profile:

👩‍🎓Education:

PhD in Genetics

  • Institution: Federal University of Uberlândia, Uberlândia, MG, Brazil
  • Year: 2008

Master’s in Genetics

  • Institution: Federal University of Uberlândia, Uberlândia, MG, Brazil
  • Year: 2008

Graduated in Veterinary Medicine

  • Institution: Federal University of Uberlândia, Uberlândia, MG, Brazil
  • Year: 2002

Post-Doctorate in Biotechnology

  • Institution: Instituto de Investigación en Recursos Cinegéticos, Universidad de Castilla-La Mancha, Ciudad Real, Castilla, Spain
  • Year: 2009

Post-Doctorate in Preventive Veterinary Medicine and Animal Health

  • Institution: Faculty of Veterinary Medicine and Animal Science, University of São Paulo, São Paulo, Brazil
  • Year: 2012

Professional Experience:

Dr. Carlos Prudencio is a distinguished scientific researcher with extensive experience in molecular biology, immunology, phage display, and the development of diagnostic biomarkers and vaccines. Since 2012, he has been a key researcher at the Immunology Center of the Adolfo Lutz Institute in São Paulo, where he also heads the Immunotech laboratory. In his role, Dr. Prudencio has led numerous high-impact research projects, including those funded by prominent organizations such as the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) and the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). His work has significantly contributed to the understanding of humoral immune responses and the development of vaccines against various pathogens, including the Zika virus and SARS-CoV-2.

Research Interest:

Dr. Prudencio’s research interests encompass molecular biology, immunology, and biotechnology, with a focus on the following areas:

Phage display technology for screening and identifying monoclonal antibodies.

Development of diagnostic biomarkers and vaccines.

Humoral immune response profiling for pathogens of public health interest.

Innovative approaches to vaccine development, particularly against emerging viral diseases.

Publications Top Noted: 

Experimental studies using OMV in a new platform of SARS-CoV-2 vaccines

  • Gaspar, E.B., Prudencio, C.R., & De Gaspari, E.
  • Human Vaccines & Immunotherapeutics, 17(9), 2965-2968, 2021
  • Citation Count: 30

Peptide mimicking antigenic and immunogenic epitope of neuwiedase from Bothrops neuwiedi snake venom

  • Cardoso, R., Homsi-Brandeburgo, M.I., Rodrigues, V.M., Santos, W.B., & Prudencio, C.R.
  • Toxicon, 53(2), 254-261, 2009
  • Citation Count: 28

Zika virus serological diagnosis: commercial tests and monoclonal antibodies as tools

  • Silva, I.B.B., Silva, A.S., Cunha, M.S., Cabral, A.D., Oliveira, K.C.A., Gaspari, E.D., & Prudencio, C.R.
  • Journal of Venomous Animals and Toxins including Tropical Diseases, 26, e20200019, 2020
  • Citation Count: 16

Different drug approaches to COVID-19 treatment worldwide: an update of new drugs and drugs repositioning to fight against the novel coronavirus

  • Oliver, J.C., Silva, E.N., Soares, L.M., Scodeler, G.C., Santos, A.S., Corsetti, P.P., & Prudencio, C.R.
  • Therapeutic Advances in Vaccines and Immunotherapy, 10, 25151355221144845, 2022
  • Citation Count: 10

Systematic surveillance and meta-analysis of antimicrobial resistance and food sources from China and the USA

  • Himanshu, Prudencio, C.R., Costa, A.C., Leal, E., Chang, C.M., & Pandey, R.P.
  • Antibiotics, 11(11), 1471, 2022
  • Citation Count: 10